In our study, we found a significant association between CYP17A1 rs743572 polymorphism with both hormone-sensitive and non-hormone-sensitive cancers, reflecting its dual role in steroid hormone synthesis and broader metabolic pathways. Here, CYP17A1 is linked to cancer.